Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2004-12-13
2011-10-25
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093210, C435S320100
Reexamination Certificate
active
08043611
ABSTRACT:
The present invention provides nucleic acid constructs, expression systems, and methods relating to the regulation of gene expression. The invention may be applied to regulate the expression of any coding sequence of interest, including those coding for viral components necessary for the packaging of viral particles.
REFERENCES:
patent: WO-99/41397 (1999-08-01), None
Gosh et al., Synergism between Tat and VP16 in Trans-activation of HIV-1 LTR, Journal of Molecular Biology, 1993, 234:610-619.
Yu et al., Inducible Human Immunodeficiency Virus Type 1 Packaging Cell Lines, Journal of Virology, 1996, 70(7):4530-4537.
Dropulic et al., PNAS USA (1996) 93:11103-11108.
Mautino et al., Human Gene Therapy (2000) 11(14):2025-2037.
Mautino et al., Gene Therapy (2000) 7(16):1421-1424.
Mautino et al., Human Gene Therapy (2000) 11(6):895-908.
“Autologous T Cells Transduced With VRX496, An HIV-1 Based Lentiviral Vector for the Treatment of Patient-Subjects Infected With HIV-1” FDA Biological Response Modifiers Advisory Committee Meeting Briefing Package, submitted by VIRxSYS Corporation on Oct. 26, 2001.
Office Action for Russian Application No. 2004116319/13(017789), date mailed on Feb. 27, 2007, 6 pages.
Prasolov and Ivanov, Retroviral Vectors in Gene Therapy, Vopr Med Khim (2000) 46(3):207-225 (English abstract included), Only English abstract considered.
Prasolov et al., Retroviral Vectors in Gene Therapy, Questions Med. Chem. (2000) 3:1-18 (with English translation of pp. 11-13).
Chang Yung-Nien
Dropulic Boro
Ni Yajin
Kinsey White Nicole
Lucas Zachariah
Morrison & Foerster / LLP
Sira, Esq. Serge
Virxsys Corporation
LandOfFree
Regulated nucleic acid expression system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated nucleic acid expression system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated nucleic acid expression system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289090